Proven translational medicine and biomarker strategy leader across early and late phase oncology drug development with a strong background in bioinformatics and molecular biology. Excels at leading interdisciplinary teams to distill large, complex datasets to focused key conclusions enabling data-driven decision making. Strong desire to make advances in personalized medicine by implementing biomarker strategies in drug development.